| Literature DB >> 35186374 |
Lianhao Wang1, Shiyi Wang2, Xiangyu Zhang1, Zhongwei Jia1,3,4.
Abstract
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: Reducing population mobility and increasing the vaccination rate for severe acute respiratory syndrome coronavirus 2 can decrease the transmission of coronavirus disease 2019 (COVID-19). WHAT IS ADDED BY THIS REPORT?: In order to reduce the incidence of COVID-19 to the levels of influenza after restoring normal mobility, the efficacy against infection needs to be increased to 40% and the efficacy against symptomatic disease needs to be increased to 90%. The efficacy against infection has a more important impact compared to efficacy against symptomatic disease or death on the transmission of COVID-19 at the population level. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE?: The population should continue maintaining non-pharmaceutical interventions and minimize international movement to prevent transmission of COVID-19. Furthermore, developing new vaccines or promoting booster vaccinations should be considered to increase efficacy. Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022.Entities:
Keywords: COVID-19; Epidemic dynamics model; Population mobility; Vaccine
Year: 2022 PMID: 35186374 PMCID: PMC8837462 DOI: 10.46234/ccdcw2022.012
Source DB: PubMed Journal: China CDC Wkly ISSN: 2096-7071